Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  • Equipment

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  • Equipment
  1. Outputs

Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor ntiretroviral regimens failed

Academic Article
Publication Date:
2004
Short description:
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor ntiretroviral regimens failed / Perno, Carlo Federico; Cozzi-Lepri, Alessandro; Violin, Michela; Cadeo, Giampiero; Orani, Anna; Chirianni, Antonio; Balotta, Claudio; Antonella, D'Arminio Monforte; Bertoli, Ada; Forbici, Federica; Mura, Maria Stella Anna; De Stefano, Carlo. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - 189:11(2004), pp. 1983-1987. [10.1086/386307]
abstract:
The association between minor mutations in human immunodeficiency
virus (HIV) protease at baseline and development
of common primary mutation 90M at virological failure (conferring
some resistance to all protease inhibitors [PIs]) was
evaluated in 93 previously drug-naive patients experiencing
failure of their first PI-based antiretroviral regimens. In logistic
regression analysis, the probability of accumulating a new 90M
mutation at virological failure was associated with the presence
at baseline of minor mutation 36I (naturally occurring in
∼25% of HIV clade B and in >80% of HIV non-clade-B viruses)
(adjusted odds ratio, 13.5 [95% confidence interval, 1.89–95.6];P=.009) and, possibly, of 10I/V. This suggests a potential role
for the presence of 36I at baseline in predicting the appearance
of 90M at virological failure.
Iris type:
1.1 Articolo in rivista
Keywords:
HIV protease; 90M mutation; protease-inhibitor; antiretroviral therapy
List of contributors:
Perno, Carlo Federico; Cozzi-Lepri, Alessandro; Violin, Michela; Cadeo, Giampiero; Orani, Anna; Chirianni, Antonio; Balotta, Claudio; Antonella, D'Arminio Monforte; Bertoli, Ada; Forbici, Federica; Mura, Maria Stella Anna; De Stefano, Carlo
Handle:
https://iris.uniss.it/handle/11388/264119
Full Text:
https://iris.uniss.it//retrieve/handle/11388/264119/195354/Perno_F_Articolo_2004_Minor.pdf
Published in:
THE JOURNAL OF INFECTIOUS DISEASES
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.1.0